Tissue Inhibitor of Metalloproteinase-1

"Tissue Inhibitor of Metalloproteinase-1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A member of the family of TISSUE INHIBITOR OF METALLOPROTEINASES. It is a N-glycosylated protein, molecular weight 28 kD, produced by a vast range of cell types and found in a variety of tissues and body fluids. It has been shown to suppress metastasis and inhibit tumor invasion in vitro.

Descriptor ID	D019715
MeSH Number(s)	D12.776.645.875.450
Concept/Terms	Tissue Inhibitor of Metalloproteinase-1 Tissue Inhibitor of Metalloproteinase-1 Metalloproteinase-1 Tissue Inhibitor Tissue Inhibitor of Metalloproteinase 1 TIMP-1

Below are MeSH descriptors whose meaning is more general than "Tissue Inhibitor of Metalloproteinase-1".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Proteinase Inhibitory Proteins, Secretory [D12.776.645]
Tissue Inhibitor of Metalloproteinases [D12.776.645.875]
Tissue Inhibitor of Metalloproteinase-1 [D12.776.645.875.450]

Below are MeSH descriptors whose meaning is related to "Tissue Inhibitor of Metalloproteinase-1".

Below are MeSH descriptors whose meaning is more specific than "Tissue Inhibitor of Metalloproteinase-1".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Tissue Inhibitor of Metalloproteinase-1" by people in this website by year, and whether "Tissue Inhibitor of Metalloproteinase-1" was a major or minor topic of these publications.

Bar chart showing 23 publications over 15 distinct years, with a maximum of 2 publications in 2004 and 2005 and 2006 and 2007 and 2010 and 2011 and 2012 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	0	1	1
2001	0	1	1
2004	2	0	2
2005	1	1	2
2006	0	2	2
2007	0	2	2
2008	1	0	1
2010	0	2	2
2011	2	0	2
2012	0	2	2
2015	0	1	1
2016	1	0	1
2018	1	0	1
2020	1	1	2
2022	1	0	1

Below are the most recent publications written about "Tissue Inhibitor of Metalloproteinase-1" by people in Profiles.

Durukan U, Agcaoglu O, Ozoran E, Karahan SN, Ozata I, Duzkoylu Y, Pasaoglu E, Aren A. The role of tissue inhibitor of metalloproteinases in the aetiology of inguinal and incisional hernias. Int Wound J. 2022 Oct; 19(6):1502-1508.

View in: PubMed
Chen J, Argemi J, Odena G, Xu MJ, Cai Y, Massey V, Parrish A, Vadigepalli R, Altamirano J, Cabezas J, Gines P, Caballeria J, Snider N, Sancho-Bru P, Akira S, Rusyn I, Gao B, Bataller R. Hepatic lipocalin 2 promotes liver fibrosis and portal hypertension. Sci Rep. 2020 09 23; 10(1):15558.

View in: PubMed
Scott RA, Robinson KG, Kiick KL, Akins RE. Human Adventitial Fibroblast Phenotype Depends on the Progression of Changes in Substrate Stiffness. Adv Healthc Mater. 2020 04; 9(8):e1901593.

View in: PubMed
Gawron K, Ochala-Klos A, Nowakowska Z, Bereta G, Lazarz-Bartyzel K, Grabiec AM, Plakwicz P, G?rska R, Fertala A, Chomyszyn-Gajewska M, Potempa J. TIMP-1 association with collagen type I overproduction in hereditary gingival fibromatosis. Oral Dis. 2018 Nov; 24(8):1581-1590.

View in: PubMed
Alqahtani MF, Smith CM, Weiss SL, Dawson S, Ralay Ranaivo H, Wainwright MS. Evaluation of New Diagnostic Biomarkers in Pediatric Sepsis: Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, Mid-Regional Pro-Atrial Natriuretic Peptide, and Adipocyte Fatty-Acid Binding Protein. PLoS One. 2016; 11(4):e0153645.

View in: PubMed
Yao R, Cao Y, He YR, Lau WB, Zeng Z, Liang ZA. Adiponectin attenuates lung fibroblasts activation and pulmonary fibrosis induced by paraquat. PLoS One. 2015; 10(5):e0125169.

View in: PubMed
Collier P, Watson CJ, Waterhouse DF, Dawkins IR, Patle AK, Horgan S, Conlon CM, O'Hanlon R, Baugh JA, Ledwidge MT, McDonald K. Progression of left atrial volume index in a population at risk for heart failure: a substudy of the STOP-HF (St Vincent's Screening TO Prevent Heart Failure) trial. Eur J Heart Fail. 2012 Sep; 14(9):957-64.

View in: PubMed
Sharma C, Nusri Qel-A, Begum S, Javed E, Rizvi TA, Hussain A. (-)-Epigallocatechin-3-gallate induces apoptosis and inhibits invasion and migration of human cervical cancer cells. Asian Pac J Cancer Prev. 2012; 13(9):4815-22.

View in: PubMed
Louboutin JP, Reyes BA, Agrawal L, Van Bockstaele EJ, Strayer DS. HIV-1 gp120 upregulates matrix metalloproteinases and their inhibitors in a rat model of HIV encephalopathy. Eur J Neurosci. 2011 Dec; 34(12):2015-23.

View in: PubMed
Leckie SK, Bechara BP, Hartman RA, Sowa GA, Woods BI, Coelho JP, Witt WT, Dong QD, Bowman BW, Bell KM, Vo NV, Wang B, Kang JD. Injection of AAV2-BMP2 and AAV2-TIMP1 into the nucleus pulposus slows the course of intervertebral disc degeneration in an in?vivo rabbit model. Spine J. 2012 Jan; 12(1):7-20.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement